CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 62 filers reported holding CHEMBIO DIAGNOSTICS INC in Q3 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $104,000 | – | 32,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,030,533 | $22,539,000 | 4.01% |
| ARS Investment Partners, LLC | 796,367 | $8,840,000 | 1.41% |
| Gagnon Advisors, LLC | 194,579 | $2,160,000 | 1.37% |
| GAGNON SECURITIES LLC | 263,894 | $2,929,000 | 0.84% |
| Benchmark Capital Advisors | 96,235 | $1,068,000 | 0.81% |
| PERKINS CAPITAL MANAGEMENT INC | 94,550 | $1,050,000 | 0.75% |
| Cortina Asset Management, LLC | 645,718 | $7,167,000 | 0.34% |
| EAM Investors, LLC | 73,327 | $814,000 | 0.13% |
| Whitegate Investment Counselors, Inc. | 11,000 | $122,000 | 0.02% |
| ROYCE & ASSOCIATES LP | 299,353 | $3,323,000 | 0.02% |